Company profile for IntelGenx

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

IntelGenx is a drug delivery company headquartered in Montreal (Quebec), which focuses on the development of novel pharmaceutical products based on its proprietary oral drug delivery technologies. The company provides pharmaceutical services to the pharmaceutical and animal health industry including development, regulatory, clinical and manufacturing services.We position our delivery technologies as an opportunity for lifecycl...
IntelGenx is a drug delivery company headquartered in Montreal (Quebec), which focuses on the development of novel pharmaceutical products based on its proprietary oral drug delivery technologies. The company provides pharmaceutical services to the pharmaceutical and animal health industry including development, regulatory, clinical and manufacturing services.We position our delivery technologies as an opportunity for lifecycle management of brand products nearing patent expiry protection of the active ingredient.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
6425 Abrams Ville St-Laurent (Quebec) H4S 1X9
Telephone
Telephone
1 514 331 7440
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/lts-and-nualtis-announce-strategic-cooperation-to-expand-global-manufacturing-capabilities-accelerate-market-expansion-and-ensure-customer-success-302490826.html

PR NEWSWIRE
25 Jun 2025

https://www.globenewswire.com/news-release/2025/06/11/3097527/0/en/IntelGenx-Announces-Rebranding-to-Nualtis-Signaling-Strategic-Evolution-and-Renewed-Vision.html

GLOBENEWSWIRE
11 Jun 2025

https://www.intelgenx.com/newsrooms/newsrooms1/134-2024-news/1020-ntelenxisrantedourtpprovalofthealeroposalfr20241002

PRESS RELEASE
02 Oct 2024

https://www.globenewswire.com/news-release/2024/07/19/2916059/0/en/IntelGenx-Provides-Update-on-Previously-Announced-Sale-and-Investment-Solicitation-Process.html

GLOBENEWSWIRE
19 Jul 2024

https://www.globenewswire.com/news-release/2024/07/03/2908117/0/en/IntelGenx-Obtains-Preliminary-Efficacy-Results-for-the-BUENA-Montelukast-VersaFilm-Phase-2a-Clinical-Trial-in-Patients-with-Mild-to-Moderate-Alzheimer-s-Disease.html

GLOBENEWSWIRE
03 Jul 2024

https://www.intelgenx.com/newsrooms/newsrooms1/134-2024-news/1017-ntelenxnnouncesnitiationofthealeandnvestment20240611

PRESS RELEASE
11 Jun 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty